Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glivec in Patients With Rising PSA Following Radical Prostatectomy
NCT01316458Phase 2Completed
- Sponsor
- Novartis
- Start
- Jun 2003
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in prostate cancer (PCa), sponsored by Novartis. Started Jun 2003; status: completed.
02
Drugs
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01316458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01316458.